Results 161 to 170 of about 202,862 (302)
Systemic Diseases and the Eye: A Translational Perspective on Diabetes
The eye–brain–cardiometabolic axis in diabetes: retinal biomarkers as indicators of systemic disease. ABSTRACT Diabetes mellitus is a global chronic disease that affects the whole body and not just glucose metabolism. In diabetes, non‐invasive ocular changes can help understand microvascular, neurodegenerative, and inflammatory processes. This analysis
Matteo Capobianco +6 more
wiley +1 more source
Electrophysiology Laboratory Survival Guide Part 2: Introduction to Intracardiac Echocardiography in the Electrophysiology Laboratory. [PDF]
Haloot J, Schurmann P.
europepmc +1 more source
Multicentre experience with the variable-loop circular catheter pulsed-field ablation system for atrial fibrillation ablation. [PDF]
Dello Russo A +19 more
europepmc +1 more source
Front Propagation Through a Perforated Wall
ABSTRACT We consider a bistable reaction– diffusion equation ut=Δu+f(u)$u_t=\Delta u +f(u)$ on RN${\mathbb {R}}^N$ in the presence of an obstacle K$K$, which is a wall of infinite span with many holes. More precisely, K$K$ is a closed subset of RN${\mathbb {R}}^N$ with smooth boundary such that its projection onto the x1$x_1$‐axis is bounded and that ...
Henri Berestycki +2 more
wiley +1 more source
Abstract Implantable cardioverter defibrillators (ICDs) reliably prevent death due to life‐threatening arrhythmias; this may become less relevant in people with more severe heart failure who are reaching the end of life (EOL). This review aimed to explore the ICD deactivation process and identify ethical issues, especially around the initiation of ...
Siobhan C. Murray +2 more
wiley +1 more source
Electrophysiology procedures for preventing falls in older people living in the community. [PDF]
Gibson K +5 more
europepmc +1 more source
Effects of SGLTi on Individual Clinical Endpoints and Quality‐of‐Life: outcome from randomized data. Abstract Aims Sodium–glucose co‐transporter inhibitors (SGLTis) have cardiovascular protective effects. We aimed to assess the effects of SGLTis on individual hard clinical endpoints and quality of life (QoL) in patients with cardiovascular risk factors.
Jia Liao +27 more
wiley +1 more source

